VC
XERS icon

VarCov Co’s Xeris Biopharma Holdings XERS Stock Holding History

VarCov Co’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$560K Buy
+70,752
New +$452K 0.21% 167
2026
Q1 		– Sell
-31,005
Closed -$243K – 664
2025
Q4 		$243K Buy
+31,005
New +$244K 0.1% 369

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

VarCov Co's XERS Position: Q2 2026 in Review

VarCov Co opened a new position in Xeris Biopharma Holdings (XERS) in Q2 2026: 70,752 shares worth $560K. The stake represents 0.21% of the portfolio and ranks #167 among its holdings. This is a return to the name: VarCov Co previously reported a position in XERS as recently as Q4 2025.

VarCov Co first reported a position in XERS in Q4 2025 and has held it in 2 quarters since. 237 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • VarCov Co held 70,752 shares of Xeris Biopharma Holdings worth $560K as of Q2 2026.
  • Xeris Biopharma Holdings was a new VarCov Co position in Q2 2026.
  • Xeris Biopharma Holdings made up 0.21% of VarCov Co's portfolio in Q2 2026, its #167 holding.
  • VarCov Co first reported a position in Xeris Biopharma Holdings in Q4 2025 and has held it in 2 quarters since.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on VarCov Co's 13F filing for Q2 2026, filed 14 Aug 2026.